Related
Technology Description

Scope of the problem

Single photon emission computed tomography (SPECT) using [123I]FP-CIT is a well-established diagnostic tool for in vivo evaluation of the nigrostriatal dopaminergic system in Parkinson’s disease (PD). SPECT images of patients suffering from PD show lower uptake in the striatum caused by the depletion of the dopamine transporter (DAT). Although diagnosis by experienced observers is mainly based on qualitative criteria, the quantification of striatal DAT binding is highly recommended to improve diagnostic accuracy. The European Association of Nuclear Medicine Neuroimaging Committee (ENC) provides guidelines for brain neurotransmission SPECT using 123I-labeled radiopharmaceuticals that include recommendations on reconstruction methods, filtering, applied data corrections and regions of interest (ROIs).
According to these guidelines, each center chooses its own image processing conditions. As a result, the quantitative values obtained from the [123I]FP-CIT SPECT images are dependent on the scanner, acquisition protocol, reconstruction parameters and ROIs. Thus, quantitative results need to be standardized before comparison with a database of normal control scans or in the case of multicenter clinical trials.<br>
Our innovation:

tQUDOSY is a set of routines necessary to implement an application that allows the quantification of SPECT studies of the dopaminergic system with the purpose of helping in its visual evaluation.
Facilitates the differential diagnosis of movement disorders (Parkinson’s disease versus other entities)and cognitive impairments (Alzheimer’s disease versus Lewy body disease)
It can also be used in the early detection of Parkinson’s disease and Lewy body disease
It could also be applied in the quantification of studies with other tracers of the nigrostriatal system (IBZM, β-CIT) or with PET studies (Positron Emission Tomography) with FDOPA
The programming language used for the development of the application is C ++
Currently the routines are available to be compiled in Windows and Linux environment

Potential Benefits

Competitive advantages:
The applications generated with the tQUDOSY routines do not require specialized technical personnel to be used. It can be compiled in any operating environment. It allows to obtain comparable standardized values between different centers and teams that use the same software, previously validated in a clinical environment.

Limitations

To be determined during further development

Suggested Applications

Patient need addressed: Parkinson’s disease, Alzheimer’s disease, Lewy body disease

Related materials
Case manager

Aida Castellanos Paez

Status
Intellectual Property was recorded by notary in Madrid, Santiago Cháfer Rudilla, No. 1.220 (03/07/2019)
Availability
Licensing or Assignment
Inventor(s)
Marti Fuster, Aida Niñerola, Raul Tudela, Domenec Ros, Albert Cot, Oscar Esteban, Francisco Lomeña, Ma. Jesus Ledesma, Andres Santos, Javier Pavia

Centro de Investigación Biomédica en Red, Bioingeniería, Biomateriales y Nanomedicina

Discover the institution >>
The Biomedical Networking Research Center of Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN) is one of the 11 thematic areas of CIBER. CIBER groups some of the main Spanish research groups (more than 400) in biomedicine, located in more than 100 institutions distributed around Spain. Website: http://www.ciber-bbn.es/